Regenerative Medicine Certification Program Introduction
The Certified Regenerative Medicine Program is designed to educate Healthcare Professionals to understand the benefits of using regenerative medicine to treat their patients. The program dives into the basics of this technology, and the overall aspects needed to incorporate regenerative medicine as part of any medical practice.
What is regenerative medicine?
According to the Advancing Transfusion and Cellular Therapies Worldwide regenerative medicine stands for:
Regenerative medicine may be defined as the process of replacing or “regenerating” human cells, tissues or organs to restore or establish normal function. This field holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue or by stimulating the body’s own repair mechanisms to heal tissues or organs. Regenerative medicine also may enable scientists to grow tissues and organs in the laboratory and safely implant them when the body is unable to heal itself. Current estimates indicate that approximately one in three Americans could potentially benefit from regenerative medicine.
Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. Examples include cell therapies (the injection of stem cells or progenitor cells); immunomodulation therapy (regeneration by biologically active molecules administered alone or as secretions by infused cells); and tissue engineering (transplantation of laboratory grown organs and tissues). While covering a broad range of applications, in practice the latter term is closely associated with applications that repair or replace portions of or whole tissues (i.e., bone, cartilage, blood vessels, bladder, skin). Often, the tissues involved require certain mechanical and structural properties for proper functioning. The term has also been applied to efforts to perform specific biochemical functions using cells within an artificially-created support system (e.g., artificial pancreas or liver).
http://www.aabb.org/aabbcct/therapyfacts/Pages/regenerative.aspx
Why is regenerative medicine important?
Based on the National Center for Biotechnology Information, Regenerative medicine: Current therapies and future directions article:
Organ and tissue loss through disease and injury motivate the development of therapies that can regenerate tissues and decrease reliance on transplantations. Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration, can potentially restore diseased and injured tissues and whole organs. Since the inception of the field several decades ago, a number of regenerative medicine therapies, including those designed for wound healing and orthopedics applications, have received Food and Drug Administration (FDA) approval and are now commercially available.
Regenerative Medicine FDA-Approved products
Category | Name | Biological agent | Approved use |
Biologics | laViv | Autologous fibroblasts | Improving nasolabial fold appearance |
Carticel | Autologous chondrocytes | Cartilage defects from acute or repetitive trauma | |
Apligraf, GINTUIT | Allogeneic cultured keratinocytes and fibroblasts in bovine collagen | Topical mucogingival conditions, leg and diabetic foot ulcers | |
Cord blood | Hematopoietic stem and progenitor cells | Hematopoietic and immunological reconstitution after myeloablative treatment | |
Cell-based medical devices | Dermagraft | Allogenic fibroblasts | Diabetic foot ulcer |
Celution | Cell extraction | Transfer of autologous adipose stem cells | |
Biopharmaceuticals | GEM 125 | PDGF-BB, tricalcium phosphate | Periodontal defects |
Regranex | PDGF-BB | Lower extremity diabetic ulcers | |
Infuse, Infuse bone graft, Inductos | BMP-2 | Tibia fracture and nonunion, and lower spine fusion |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664309/
Regenerative Medicine Certified Operator (RMCO) Hyaluronan Acid Therapies for Osteoarthritis of The Knee
The Regenerative Medicine Certified Operator Hyaluronan Acid Therapies for Osteoarthritis of the knee is the first course tier of a three-level certification program. The RMCO is the basic level and the same has been designed to ensure that individuals that complete this program have a basic understanding of Regenerative Medicine, its benefits and the proper application as an alternative treatment.
This particular course work consists of 9 sessions and a short test after completion of these sessions. Once the previously mentioned work has been completed and the individual passes the RMCO test he/she will be awarded the Regenerative Medicine Certified Operator Hyaluronan Acid Therapies for Osteoarthritis of the Knee accreditation.
As the name implies the Hyaluronan Acid Therapies for Osteoarthritis of the knee certification refers to a series of course covering Osteoarthritis and the use of Viscosupplementation with intra-articular (IA) hyaluronic acid (HA) as a treatment option.
RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee Certification Test
The RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee certification test consists of approximately 45 questions covering the basics of Hyaluronan Acid Therapies for Osteoarthritis of the knee. The test is timed and candidates have approximately one hour to complete the same.
The RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee test can only be taken at specified testing centers at specified designated dates. The RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee test is normally scheduled as part of the EPI Compliance conference but additional dates and locations may be pre-arranged on a case by case basis.
Prerequisite Requirements
There are no prerequisites for this level nor are there any other educational qualifications required.
Test Composition
The RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee test is based on 5 sections. The actual distribution of questions and scores is as follows:
Section | Description | Score (%) |
1 | Anatomy of the knee | 25 |
2 | Osteoarthritis of the Knee | 25 |
3 | Diagnosis and Treatments | 25 |
4 | Regenerative Medicine for the knee | 25 |
Obtaining the RMCO Hyaluronan Acid Therapies for Osteoarthritis of the Knee certification is based on candidates passing every section with a minimum score of 70%.
Exam retake policy
Individuals failing to pass the test may be scheduled for an online re-testing section or they can choose to retest at the next scheduled session.
Post Certification Requirements/Renewal
RMCO certification is valid for a period of three years. RMCO’s must complete at least three Regenerative Medicine certified courses within this period.
-
Regenerative Medicine Certification (level 2): Hyaluronan Acid Therapies for Osteoarthritis of the Knee
Registration
7:30 -
Introduction
8:00 -
Anatomy of knee
Common Knee Pathology
9:00Osteoarthritis of the knee
Physical exam of knee
10:30Lunch
12:00Diagnostic imaging of knee
1:00Viscosupplementation for osteoarthritis of knee
2:00Medicare rules - "Super LCD"
3:00Knee Bracing
3:30Regenerative medicine for knee osteoarthritis
4:00Questions and Answers
4:30Friday Schedule-
Intro to Regenerative Medicine
Registration
8:00 -
What is Regenerative Medicine?
What is platelet-rich plasma (PRP) and what are PRP injections?
8:30 9:00 10:00 -
Aesthetics of Regenerative Medicine
10:30 11:00Lunch
12:00Sexual Health
1:00Orthopedics
2:00Lower Body and Peripheral Neuropathy
3:00Q&A: Panel Discussion
3:30Saturday Schedule-
Welcome and Registration - Dr. Jose Delgado
8:30 -
Wound Care and Hyperbaric therapies Dr. Yesenia Justiniano
9:00 -
Wound Care skin grafts and other alternatives - Dr. Rosana Roriguez
10:00Infrared uses in diagnostics - Dr. Dr Jorma Lahtela
11:00Legally Mine Luncheon
12:00"Managing Pain (Under the Microscope). “Electroanalgesia is a form of analgesia, or pain relief, that uses electricity to ease pain. Electrical devices can be internal or external, at the site of pain or delocalized throughout the whole body.” -Wikipedia. In this presentation, Peter Beltran, President/CEO of Neuromed, will explain the uses of electroanalgesia and the changes in the market which makes this option a perfect alternative for the treatment of chronic and acute pain."
1:30CBD as a tool for the Medical Practice - Dr. Lora Brown
2:30Introduction to Regenerative Medicine Part 1 - Dr. Rosana Rodriguez
3:30Closing and Awards Ceremony
4:30